Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Beta Bionics, Inc. (BBNX) had Gross Margin of 55.40% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$100.25M |
|
$-73.20M |
|
$44.71M |
|
$55.54M |
|
$171.93M |
|
$-71.68M |
|
$-1.52M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-71.68M |
|
$-68.81M |
|
40.53M |
|
40.53M |
|
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$267.90M |
|
$8.60M |
|
$60.84M |
|
$328.74M |
|
$30.92M |
|
-- |
|
$10.21M |
|
$41.13M |
|
$287.61M |
|
$287.61M |
|
$287.61M |
|
44.36M |
|
| Cash Flow Statement Financials | |
$-50.92M |
|
$-162.81M |
|
$214.87M |
|
$30.53M |
|
$31.68M |
|
$1.14M |
|
$16.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
55.40% |
-71.50% |
|
-71.50% |
|
-68.63% |
|
-73.02% |
|
-73.02% |
|
$-332.96M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
2.06 |
|
5.86 |
|
62.32 |
|
-25.45% |
|
-25.45% |
|
-22.27% |
|
-25.45% |
|
$6.48 |
|
$-8.22 |
|
$-1.26 |
|